Recursion to Participate in Upcoming Investor Conferences
Recursion (NASDAQ: RXRX), a clinical stage TechBio company, has announced its upcoming participation in two major investor conferences in May 2025. The company will be presenting at the Bank of America 2025 Health Care Conference on Tuesday, May 13, and the JP Morgan Global Technology, Media and Communications Conference on Thursday, May 15. Interested parties can access the webcasts through Recursion's Investor Relations website at ir.recursion.com.
Recursion (NASDAQ: RXRX), un'azienda TechBio in fase clinica, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. La società presenterà al Bank of America 2025 Health Care Conference martedì 13 maggio e al JP Morgan Global Technology, Media and Communications Conference giovedì 15 maggio. Gli interessati potranno seguire le webcasts sul sito delle Relazioni con gli Investitori di Recursion all'indirizzo ir.recursion.com.
Recursion (NASDAQ: RXRX), una empresa TechBio en etapa clínica, ha anunciado su próxima participación en dos importantes conferencias para inversores en mayo de 2025. La compañía presentará en la Bank of America 2025 Health Care Conference el martes 13 de mayo y en la JP Morgan Global Technology, Media and Communications Conference el jueves 15 de mayo. Los interesados podrán acceder a las transmisiones web a través del sitio web de Relaciones con Inversores de Recursion en ir.recursion.com.
Recursion (NASDAQ: RXRX)는 임상 단계의 TechBio 기업으로, 2025년 5월 두 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 5월 13일 화요일에 열리는 Bank of America 2025 Health Care Conference와 5월 15일 목요일에 열리는 JP Morgan Global Technology, Media and Communications Conference에서 발표할 예정입니다. 관심 있는 분들은 Recursion 투자자 관계 웹사이트 ir.recursion.com을 통해 웹캐스트를 시청할 수 있습니다.
Recursion (NASDAQ : RXRX), une entreprise TechBio en phase clinique, a annoncé sa participation prochaine à deux grandes conférences pour investisseurs en mai 2025. La société présentera lors de la Bank of America 2025 Health Care Conference le mardi 13 mai, ainsi qu'à la JP Morgan Global Technology, Media and Communications Conference le jeudi 15 mai. Les personnes intéressées pourront accéder aux webcasts via le site des Relations Investisseurs de Recursion à l'adresse ir.recursion.com.
Recursion (NASDAQ: RXRX), ein klinisch tätiges TechBio-Unternehmen, hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 angekündigt. Das Unternehmen wird am Bank of America 2025 Health Care Conference am Dienstag, den 13. Mai, sowie am JP Morgan Global Technology, Media and Communications Conference am Donnerstag, den 15. Mai, präsentieren. Interessierte können die Webcasts über die Investor-Relations-Website von Recursion unter ir.recursion.com verfolgen.
- None.
- None.
Salt Lake City, May 06, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
- Bank of America 2025 Health Care Conference — Tuesday, May 13, 2025
- JP Morgan Global Technology, Media and Communications Conference — Thursday, May 15, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Media Contact
Media@Recursion.com
Investor Contact
Investor@Recursion.com
Ryan Kelly Recursion Pharmaceuticals media@recursion.com
FAQ
When is Recursion (RXRX) presenting at the Bank of America Healthcare Conference 2025?
What investor conferences is Recursion (RXRX) attending in May 2025?
Where can I watch Recursion's (RXRX) investor conference presentations?
When is Recursion (RXRX) presenting at the JP Morgan Global Technology Conference 2025?
